Correction to: PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID (Journal of Clinical Immunology, (2023), 43, 5, (951-964), 10.1007/s10875-022-01426-y)

Morna J. Dorsey, Arye Rubinstein, Heather Lehman, Tracy Fausnight, Joseph M. Wiley, Elie Haddad

Research output: Contribution to journalComment/debatepeer-review


The original version of this article contained an error in Table 4 under “total number of hospitalizations”. The corresponding information in the text was correct. The corrected table is presented below: (Table presented.) Summary of infections and hospitalizations Elapegademase N = 7 Patients with infection, n (%) 5 (71.4) Total number of infections, n 26 Patients with hospitalization, n (%) 3 (42.9) Total number of hospitalizations, n (%) 1 2 (28.6) 2 1 (14.3) 3 0 (0.0) Duration of hospitalization, days 4 Mean 5.0 SD 2.16 Median 5.5 Min 2 Max 7 Reason for hospitalization, na Dehydration 1 Hemoptysis 1 Respiratory tract infection 1 Tooth abscess 1 Vestibular migraine 1 Duration of hospitalization = (end date of hospitalization – start date) + 1. aPatients can be admitted more than once so “n” can be larger than the number of patients, and row totals can sum to more than the number of patients Max, maximum, Min, minimum, SD, standard deviation.

Original languageEnglish (US)
Pages (from-to)1671-1672
Number of pages2
JournalJournal of Clinical Immunology
Issue number7
StatePublished - Oct 2023

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this